Hyperliquid Strategies Inc (NASDAQ:PURR – Get Free Report) saw unusually-strong trading volume on Wednesday after Chardan Capital raised their price target on the stock from $8.45 to $9.75. Chardan Capital currently has a buy rating on the stock. Approximately 3,233,629 shares changed hands during trading, a decline of 38% from the previous session’s volume of 5,192,967 shares.The stock last traded at $7.9790 and had previously closed at $7.79.
PURR has been the subject of a number of other research reports. Maxim Group started coverage on Hyperliquid Strategies in a research report on Friday, April 24th. They set a “buy” rating and a $10.00 price objective for the company. Cantor Fitzgerald upped their price target on shares of Hyperliquid Strategies from $6.00 to $8.00 and gave the company an “overweight” rating in a research report on Monday, May 11th. Wall Street Zen raised shares of Hyperliquid Strategies to a “hold” rating in a report on Saturday, February 21st. Finally, Weiss Ratings initiated coverage on shares of Hyperliquid Strategies in a research report on Monday, March 2nd. They set a “sell (e)” rating for the company. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $9.25.
Get Our Latest Stock Report on PURR
Institutional Inflows and Outflows
Hyperliquid Strategies Price Performance
The firm’s 50-day simple moving average is $5.90. The stock has a market cap of $1.09 billion, a PE ratio of -1.07 and a beta of 1.44.
Hyperliquid Strategies (NASDAQ:PURR – Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported $1.01 earnings per share (EPS) for the quarter. The business had revenue of $2.63 million during the quarter. As a group, equities research analysts anticipate that Hyperliquid Strategies Inc will post -1.15 EPS for the current year.
About Hyperliquid Strategies
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Read More
- Five stocks we like better than Hyperliquid Strategies
- Tesla Ends Model S and X Era, Bets Everything on What’s Next
- Why AST SpaceMobile Is the Bigger Winner of the AT&T, T-Mobile, and Verizon Joint Venture
- Strategy Inc. Buys Bitcoin and Eyes a Dividend Amid Market Fear
- Vertical Aerospace: Pre-Flight Checks Point to a Breakout
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
